Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPA5 | P11021 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | HTR1A | P08908 | 1/20 | 0.35 |
| ▸ | TACR2 | P21452 | 1/20 | 0.34 |
| ▸ | PDE2A | O00408 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 6/20 | 0.33 |
| ▸ | CDC25B | P30305 | 6/20 | 0.33 |
| ▸ | GJB2 | P29033 | 2/20 | 0.33 |
| ▸ | SSTR4 | P31391 | 2/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.33 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.33 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.33 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.33 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.32 |
| ▸ | PTPN6 | P29350 | 2/20 | 0.32 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2450072 | 0.81 | TACR2 (0.35) | HSPA5SLC6A2HTR1ATACR2PTPN1 | |
| SCHEMBL8655409 | 0.79 | HTR1A (0.43) | HTR1ATACR2PTPN1CDC25BGJB2 | |
| SCHEMBL9148642 | 0.75 | GJB2 (0.47) | TACR2PTPN1CDC25BGJB2PTPN2 | |
| SCHEMBL2455059 | 0.74 | PTPN1 (0.38) | HTR1ATACR2PTPN1CDC25BPTPN2 | |
| SCHEMBL260047 | 0.71 | TACR2 (0.39) | SLC6A2HTR1ATACR2PTPN1CDC25B | |
| SCHEMBL1961043 | 0.70 | GJB2 (0.45) | HSPA5SLC6A2PTPN1CDC25BGJB2 | |
| SCHEMBL1780241 | 0.70 | GJB2 (0.45) | HSPA5SLC6A2PTPN1CDC25BGJB2 | |
| SCHEMBL8374052 | 0.70 | SLC6A2 (0.58) | HSPA5SLC6A2PTPN1CDC25BGJB2 | |
| SCHEMBL21878075 | 0.70 | SLC6A2 (0.58) | HSPA5SLC6A2PTPN1CDC25BGJB2 | |
| SCHEMBL8374053 | 0.70 | SLC6A2 (0.58) | HSPA5SLC6A2PTPN1CDC25BGJB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8318696-B2 | Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative | SANOFI (FR) | 2012-11-27 | — | — | US | disclosed |
| US-20110144042-A1 | Novel Polysaccharides with Antithrombotic Activity Comprising at Least One Covalent Bond with Biotin or a Biotin Derivative | SANOFI-AVENTIS (FR) | 2011-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110144042-A1 | Novel Polysaccharides with Antithrombotic Activity Comprising at Least One Covalent Bond with Biotin or a Biotin Derivative | SERPINC1, SELP, FGB | HSPA5 3361/4885SLC6A2 4762/4885HTR1A 4378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.